Jun 26, 2025, 12:58
Welcoming Opposition to ISTH 2025: EHC Highlights the Crucial Role of Modern Treatments in Hemophilia Management
The European Haemophilia Consortium shared a post on X:
”The EHC attended ISTH 2025, where Maria Elisa Mancuso & Mark Skinner presented manuscripts we co-authored opposing the ISTH Guidelines. Thanks, Maria Elisa Mancuso (EHC Medical Advisory Group Chair), for representing our community at this pivotal moment!”
Apparently, no field is safe from a clash of clans!
The European Haemophilia Consortium eagerly took the stage to brand the ISTH guidelines as “outdated and purposeless” when it comes to acknowledging ”Modern Hemophilia Treatments”.
Maria Elisa Mancuso, Chair of the EHC Medical Advisory Group, and Mark Skinner presented sharply contrasting manuscripts that stirred the debate.
Stay updated on the World of Hemophilia with Hemostasis Today.
-
Aug 25, 2026, 00:07Muhammad Ali Khan: Using EHR Data to Predict Fibrotic Progression in PV and ET
-
Aug 25, 2026, 00:06Michael R. Scoma: The Vascular Dimension of Long COVID
-
Aug 24, 2026, 23:40Vimee Bindra: Your Period May Be Trying to Tell You Something
-
Aug 24, 2026, 23:30R. P. Singh: Hemophilia and HIV Relationship
-
Aug 24, 2026, 23:12Marta Velia Antonini: Hemolysis in ECMO – More Than Just a Laboratory Finding
-
Aug 24, 2026, 18:13Chokri Ben Lamine: Ruxolitinib – Comprehensive Clinical Reference
-
Aug 24, 2026, 18:10Yazan Abou-Ismail: ClotCast Episode 8 – What Are Platelets?
-
Aug 24, 2026, 17:11Kristin Neves: Which Hematologic Parameters Guide Your PV Treatment Decisions?
-
Aug 24, 2026, 17:00Should Hormone Therapy Automatically Stop After a Thrombosis? – Thrombosis Canada